Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by beta-adrenergic stimulation.

Standard

Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by beta-adrenergic stimulation. / Tiegs, Gisa; Bang, R; Neuhuber, W L.

in: J NEUROIMMUNOL, Jahrgang 96, Nr. 2, 2, 1999, S. 131-143.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{000c5d8a1a694b01bee5ff919b6a581a,
title = "Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by beta-adrenergic stimulation.",
abstract = "To investigate the interaction between the peripheral nervous and the immune system in vivo, we used two mouse models of T cell and TNF-alpha dependent liver injury inducible by either concanavalin A or a combination of D-galactosamine and staphylococcal enterotoxin B. Mice depleted of peptidergic sensory nerve fibres by capsaicin were protected from liver injury. Moreover, TNF-alpha production was significantly reduced. Examination of the effect of catecholamines on liver injury showed that the beta2-adrenergic agonist salbutamol prevented, whereas chemical sympathectomy by 6-hydroxydopamine, deteriorated the disease. Hence, strategies reducing the activity of peptidergic sensory nerve fibres or stimulating beta2-adrenoreceptors, may be of benefit in immune-mediated liver disease.",
keywords = "Animals, Male, Mice, Mice, Inbred BALB C, Capsaicin/pharmacology, Adrenergic beta-Agonists/pharmacology, Albuterol/pharmacology, Catecholamines/physiology, Hepatitis, Animal/pathology/*physiopathology, Immune System Diseases/*physiopathology, Liver/innervation/pathology, Nerve Fibers/metabolism, Neurons, Afferent/drug effects/*physiology, Receptors, Adrenergic, beta/*physiology, Sympathectomy, Chemical, Animals, Male, Mice, Mice, Inbred BALB C, Capsaicin/pharmacology, Adrenergic beta-Agonists/pharmacology, Albuterol/pharmacology, Catecholamines/physiology, Hepatitis, Animal/pathology/*physiopathology, Immune System Diseases/*physiopathology, Liver/innervation/pathology, Nerve Fibers/metabolism, Neurons, Afferent/drug effects/*physiology, Receptors, Adrenergic, beta/*physiology, Sympathectomy, Chemical",
author = "Gisa Tiegs and R Bang and Neuhuber, {W L}",
year = "1999",
language = "English",
volume = "96",
pages = "131--143",
journal = "J NEUROIMMUNOL",
issn = "0165-5728",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by beta-adrenergic stimulation.

AU - Tiegs, Gisa

AU - Bang, R

AU - Neuhuber, W L

PY - 1999

Y1 - 1999

N2 - To investigate the interaction between the peripheral nervous and the immune system in vivo, we used two mouse models of T cell and TNF-alpha dependent liver injury inducible by either concanavalin A or a combination of D-galactosamine and staphylococcal enterotoxin B. Mice depleted of peptidergic sensory nerve fibres by capsaicin were protected from liver injury. Moreover, TNF-alpha production was significantly reduced. Examination of the effect of catecholamines on liver injury showed that the beta2-adrenergic agonist salbutamol prevented, whereas chemical sympathectomy by 6-hydroxydopamine, deteriorated the disease. Hence, strategies reducing the activity of peptidergic sensory nerve fibres or stimulating beta2-adrenoreceptors, may be of benefit in immune-mediated liver disease.

AB - To investigate the interaction between the peripheral nervous and the immune system in vivo, we used two mouse models of T cell and TNF-alpha dependent liver injury inducible by either concanavalin A or a combination of D-galactosamine and staphylococcal enterotoxin B. Mice depleted of peptidergic sensory nerve fibres by capsaicin were protected from liver injury. Moreover, TNF-alpha production was significantly reduced. Examination of the effect of catecholamines on liver injury showed that the beta2-adrenergic agonist salbutamol prevented, whereas chemical sympathectomy by 6-hydroxydopamine, deteriorated the disease. Hence, strategies reducing the activity of peptidergic sensory nerve fibres or stimulating beta2-adrenoreceptors, may be of benefit in immune-mediated liver disease.

KW - Animals

KW - Male

KW - Mice

KW - Mice, Inbred BALB C

KW - Capsaicin/pharmacology

KW - Adrenergic beta-Agonists/pharmacology

KW - Albuterol/pharmacology

KW - Catecholamines/physiology

KW - Hepatitis, Animal/pathology/physiopathology

KW - Immune System Diseases/physiopathology

KW - Liver/innervation/pathology

KW - Nerve Fibers/metabolism

KW - Neurons, Afferent/drug effects/physiology

KW - Receptors, Adrenergic, beta/physiology

KW - Sympathectomy, Chemical

KW - Animals

KW - Male

KW - Mice

KW - Mice, Inbred BALB C

KW - Capsaicin/pharmacology

KW - Adrenergic beta-Agonists/pharmacology

KW - Albuterol/pharmacology

KW - Catecholamines/physiology

KW - Hepatitis, Animal/pathology/physiopathology

KW - Immune System Diseases/physiopathology

KW - Liver/innervation/pathology

KW - Nerve Fibers/metabolism

KW - Neurons, Afferent/drug effects/physiology

KW - Receptors, Adrenergic, beta/physiology

KW - Sympathectomy, Chemical

M3 - SCORING: Journal article

VL - 96

SP - 131

EP - 143

JO - J NEUROIMMUNOL

JF - J NEUROIMMUNOL

SN - 0165-5728

IS - 2

M1 - 2

ER -